RESUMEN
BACKGROUND: Immune checkpoint inhibitor (ICI) therapy for patients undergoing cancer treatment carries a risk of severe immune-related adverse events (IRAEs). Questions remain about whether seasonal influenza vaccination might increase the risk of developing IRAEs among these patients given that vaccines are immunomodulatory. Previous vaccine safety studies on patients with cancer prescribed ICI therapy have demonstrated conflicting results. METHODS: Using health administrative data from Ontario, Canada among adults diagnosed with cancer who had been prescribed ICI therapy and who had received an influenza vaccine from 2012 to 2019, we conducted a self-controlled case series study. The pre-vaccination control period started 42-days post-ICI initiation until 14-days prior to vaccination, the risk period was 1-42 days post-vaccination, and the post-vaccination control period was after the risk period until ICI discontinuation or a maximum period of two years. Emergency department (ED) visit(s) and/or hospitalization for any cause after ICI initiation was used to identify severe IRAEs. We fitted a fixed-effects Poisson regression model accounting for seasonality and calendar time to estimate relative incidence of IRAEs between risk and control periods. RESULTS: We identified 1133 records of cancer patients who received influenza vaccination while prescribed ICI therapy. Most were aged ≥ 66 years (73 %), were male (63 %), had lung cancer (54 %), and had received ICI therapy with a programmed cell death protein 1(PD-1) inhibitor (91 %). A quarter (26 %) experienced an ED visit and/or hospitalization during the observation period. Rates of ED visits and/or hospitalizations in the risk vs. control periods were similar, with an incidence rate ratio of 1.04 (95 % CI: 0.75-1.45). Subgroup and sensitivity analyses yielded similar results. CONCLUSION: Seasonal influenza vaccination was not associated with an increased incidence of ED visit or hospitalization among adults with cancer treated with ICI therapy and our results support further evidence of vaccine safety.
Asunto(s)
Vacunas contra la Influenza , Gripe Humana , Neoplasias Pulmonares , Neoplasias , Adulto , Humanos , Masculino , Femenino , Inhibidores de Puntos de Control Inmunológico/efectos adversos , Gripe Humana/prevención & control , Gripe Humana/etiología , Estaciones del Año , Proyectos de Investigación , Vacunación/efectos adversos , Ontario/epidemiología , Estudios RetrospectivosRESUMEN
This Medical News article discusses the risk to humans from the currently circulating highly pathogenic avian influenza A(H5N1) virus.
Asunto(s)
Aves , Brotes de Enfermedades , Gripe Aviar , Gripe Humana , Mamíferos , Animales , Humanos , Aves/virología , Brotes de Enfermedades/prevención & control , Gripe Aviar/epidemiología , Gripe Aviar/prevención & control , Gripe Aviar/transmisión , Gripe Humana/epidemiología , Gripe Humana/etiología , Gripe Humana/prevención & control , Gripe Humana/virología , Estudios Longitudinales , Mamíferos/virologíaRESUMEN
INTRODUCTION: Although hospital-acquired influenza infection (HAII) is a known complication among immunocompromised patients, the data in the setting of hospitalization for allogeneic hematopoietic stem cell transplant (allo-HSCT) are scarce. METHODS: A retrospective study using the National Inpatient sample database was done to determine the impact of HAII on hospitalization outcomes among patients admitted for allo-HSCT. RESULTS: The data for 77 103 allo-HSCT weighted hospitalizations were collected between 2002 and 2019. Among these, only 314 (0.4%) allo-HSCT cases were billed for HAII. Patients with influenza were more likely to have comorbid conditions like chronic obstructive lung disease, diabetes mellitus, hypertension, and myocardial infarction. Multivariate logistic regression revealed that patients with influenza had a higher risk of all-cause mortality: (odds ratio = 4.87, 95% confidence interval: 3.63-6.54; p < .01). Patients with influenza also had statistically higher odds of developing acute kidney injury, septic shock, and respiratory failure requiring mechanical ventilation. They also had a significantly longer length of stay (34 days versus 26 days) and adjusted cost for hospitalization ($195 345 versus $121 967). CONCLUSION: Our large analysis of real-world data reveals that patients undergoing allo-HSCT that develop HAII are at substantially higher risk of inpatient complications and death.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Gripe Humana , Humanos , Estudios Retrospectivos , Gripe Humana/epidemiología , Gripe Humana/etiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Hospitalización , HospitalesRESUMEN
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been raging since the end of 2019 and has shown worse outcomes in solid organ transplant (SOT) recipients. The clinical differences as well as outcomes between respiratory viruses have not been well defined in this population. METHODS: This is a retrospective cohort study of adult SOT recipients with nasopharyngeal swab or bronchoalveolar lavage PCR positive for either SARS-CoV-2, seasonal coronavirus, respiratory syncytial virus (RSV) or influenza virus from January 2017 to October 2020. The follow up period was 3 months. Clinical characteristics and outcomes were evaluated. RESULTS: A total of 377 recipients including 157 SARS-CoV-2, 70 seasonal coronavirus, 50 RSV and 100 influenza infections were identified. The most common transplanted organ was kidney 224/377 (59.4%). Lower respiratory tract infection (LRTI) was found in 210/377 (55.7%) and the risk factors identified with multivariable analysis were SARS-CoV-2 infection, steroid use, and older age. Co- and secondary infections were seen in 77/377 (20.4%) recipients with bacterial pathogens as dominant. Hospital admission was seen in 266/377 (67.7%) recipients without significant statistical difference among viruses, however, ICU admission, mechanical ventilation and mortality were higher with SARS-CoV-2 infection. In the multivariable model, the risk factors for mortality were SARS-CoV-2 infection and older age. CONCLUSIONS: We found higher incidence of ICU admission, mechanical ventilation, and mortality among SARS-CoV-2 infected recipients. Older age was found to be the risk factor for lower respiratory tract infection and mortality for SARS-CoV-2, coronaviruses, RSV and influenza virus groups.
Asunto(s)
COVID-19 , Gripe Humana , Trasplante de Órganos , Infecciones por Virus Sincitial Respiratorio , Infecciones del Sistema Respiratorio , Adulto , Humanos , SARS-CoV-2 , Gripe Humana/etiología , Estudios Retrospectivos , Estaciones del Año , Trasplante de Órganos/efectos adversos , Virus Sincitiales Respiratorios , Receptores de TrasplantesRESUMEN
BACKGROUND AND OBJECTIVES: In 2014, the European Medicines Agency (EMA) set out requirements for an enhanced safety surveillance for seasonal influenza vaccines. This paper presents data from the yearly Enhanced Passive Safety Surveillance (EPSS) implemented for Influvac® since season 2014/15 and continued for Influvac® Tetra from season 2018/19 onwards. METHODS: In seven consecutive seasons, an EPSS, aiming for at least 1,000 vaccinees (additional target of 100 vaccinees per five predefined age groups), was conducted in Germany, where market characteristics were expected to allow for a quick generation of representative data. Reactogenicity data in terms of reporting rates, severity and duration of pre-specified local and systemic adverse events of interest (AEI) were collected using response cards, which were completed by vaccinees and returned seven days after vaccination via regular mail. In addition, response cards contained a call center number to enhance reporting of other than pre-specified adverse events. RESULTS: The primary target of at least 1,000 vaccinees was surpassed in all seasons, as was the additional target of 100 adults and elderly. Reactogenicity data were in line with known safety profile of Influvac® and Influvac® Tetra. In children, the target was mostly met in seasons when the EPSS was conducted for Influvac®, but not in seasons when it was conducted for Influvac® Tetra. Although the data for Influvac® Tetra are based on a low number of paediatric vaccinees, they do not indicate a different reactogenicity profile of Influvac® Tetra compared with Influvac®. No signals were identified. CONCLUSION: The EPSS set up for Influvac® and Influvac® Tetra proved a robust and effective methodology to comply with the objectives of EMÁ's guidance on enhanced safety surveillance of seasonal influenza vaccines. Safety data from seven consecutive seasons confirmed the favourable safety profile of both vaccines.
Asunto(s)
Vacunas contra la Influenza , Gripe Humana , Adulto , Niño , Humanos , Anciano , Vacunas contra la Influenza/efectos adversos , Estaciones del Año , Gripe Humana/prevención & control , Gripe Humana/etiología , Vacunación/efectos adversosRESUMEN
BACKGROUND: Evidence concerning effects of air pollution on influenza-like illness (ILI) from multi-center is limited and little is known about how regional factors might modify this relationship. METHODS: In this ecological study, ILI cases defined as outpatients with temperature ≥38 °C, accompanied by cough or sore throat, were collected from National Influenza Surveillance Network in China. We adopted generalized additive model with quasi-Poisson to estimate province-specific association between air pollution and ILI in 30 Chinese provinces during 2015-2019, after adjusting for time trend and meteorological factors. We then pooled province-specific association by using random-effect meta-analysis. Potential effect modifications of season and regional characteristics were explored. FINDINGS: A total of 26, 004, 853 ILI cases and 777, 223, 877 hospital outpatients were collected. In general, effects of air pollutants were acute. An inter-quartile range increase of PM2.5, SO2, PM10, NO2 and CO at lag0, and O3 at lag0-2 was associated with 3.08% (95% CI: 1.91%, 4.27%), 3.00% (1.86%, 4.16%), 6.46% (4.71%, 8.25%), 7.21% (5.73%, 8.71%), 4.37% (3.05%, 5.70%), and -9.26% (-11.32%, -7.14%) change of ILI at national level, respectively. Associations between air pollutants and ILI varied by season and regions, with higher effect estimates in cold season, eastern and central regions and provinces with more humid condition and larger population. INTERPRETATION: This study indicated that most air pollutants increased the risk of ILI in China. Our findings might provide implications for the development of policies to protect public health from air pollution and influenza. FUNDING: National Natural Science Foundation of China and Chongqing Health Commission Program.
Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Gripe Humana , Humanos , Gripe Humana/epidemiología , Gripe Humana/etiología , Contaminación del Aire/efectos adversos , Contaminantes Atmosféricos/efectos adversos , Contaminantes Atmosféricos/análisis , China/epidemiología , Estaciones del Año , Material Particulado/efectos adversos , Material Particulado/análisisRESUMEN
BACKGROUND: Before COVID-19, the previous pandemic was caused by influenza A(H1N1)pdm09 virus in 2009. Identification of factors behind parental decisions to have their child vaccinated against pandemic influenza could be helpful in planning of other pandemic vaccination programmes. We investigated the association of parental socioeconomic and psychosocial factors with uptake of the pandemic influenza vaccine in children in 2009-2010. METHODS: This study was conducted within a prospective birth-cohort study (STEPS Study), where children born in 2008-2010 are followed from pregnancy to adulthood. Demographic and socioeconomic factors of parents were collected through questionnaires and vaccination data from electronic registers. Before and after the birth of the child, the mother's and father's individual and relational psychosocial well-being, i.e. depressive symptoms, dissatisfaction with the relationship, experienced social and emotional loneliness, and maternal anxiety during pregnancy, were measured by validated questionnaires (BDI-II, RDAS, PRAQ, and UCLA). RESULTS: Of 1020 children aged 6-20 months at the beginning of pandemic influenza vaccinations, 820 (80%) received and 200 (20%) did not receive the vaccine against influenza A(H1N1)pdm09. All measures of parents' psychosocial well-being were similar between vaccinated and non-vaccinated children. Children of younger mothers had a higher risk of not receiving the influenza A(H1N1)pdm09 vaccine than children of older mothers (OR 2.59, 95% CI 1.52-4.43, for mothers < 27.7 years compared to ≥ 33.6 years of age). Children of mothers with lower educational level had an increased risk of not receiving the vaccine (OR 1.46, 95% CI 1.00-2.14). CONCLUSIONS: Mother's younger age and lower education level were associated with an increased risk for the child not to receive the 2009 pandemic influenza vaccine, but individual or relational psychosocial well-being of parents was not associated with children's vaccination. Our findings suggest that young and poorly educated mothers should receive targeted support in order to promote children's vaccinations during a pandemic.
Asunto(s)
COVID-19 , Subtipo H1N1 del Virus de la Influenza A , Vacunas contra la Influenza , Gripe Humana , Adolescente , Adulto , Niño , Estudios de Cohortes , Femenino , Humanos , Gripe Humana/epidemiología , Gripe Humana/etiología , Gripe Humana/prevención & control , Padres/psicología , Embarazo , Estudios Prospectivos , Factores Socioeconómicos , VacunaciónRESUMEN
OBJECTIVES: This study aimed to explore clinical indexes for management of severe/critically ill patients with COVID-19, influenza A H7N9, and H1N1 pneumonia by comparing hematological and radiological characteristics. METHODS: Severe/critically ill patients with COVID-19, H7N9, and H1N1 pneumonia were retrospectively enrolled. The demographic data, clinical manifestations, hematological parameters, and radiological characteristics were compared. RESULTS: In this study, 16 cases of COVID-19, 10 cases of H7N9, and 13 cases of H1N1 who met severe/critically ill criteria were included. Compared with COVID-19, H7N9 and H1N1 groups had more chronic diseases (80% and 92.3% vs. 25%, p < 0.05), higher APACHE â ¡ scores (16.00 ± 8.63 and 15.08 ± 6.24, vs. 5.50 ± 2.58, p < 0.05), higher mortality rates (40% and 46.2% vs. 0%, p < 0.05), significant lymphocytopenia (0.59 ± 0.31 × 109 /L and 0.56 ± 0.35 × 109 /L vs. 0.97 ± 0.33 × 109 /L, p < 0.05), and elevated neutrophil-to-lymphocyte ratio (NLR; 14.67 ± 6.10 and 14.64 ± 10.36 vs. 6.29 ± 3.72, p < 0.05). Compared with the H7N9 group, ground-glass opacity (GGO) on chest CT was common in the COVID-19 group (p = 0.028), while pleural effusion was rare (p = 0.001). CONCLUSIONS: The NLR can be used as a clinical parameter for the predication of risk stratification and outcome in COVID-19 and influenza A pneumonia. Manifestations of pleural effusion or GGO in chest CT may be helpful for the identification of different viral pneumonia.
Asunto(s)
COVID-19/sangre , COVID-19/diagnóstico por imagen , Gripe Humana/sangre , Gripe Humana/diagnóstico por imagen , Anciano , Anciano de 80 o más Años , Recuento de Células Sanguíneas , COVID-19/etiología , Enfermedad Crónica , Enfermedad Crítica , Femenino , Humanos , Subtipo H1N1 del Virus de la Influenza A , Subtipo H7N9 del Virus de la Influenza A , Gripe Humana/etiología , Gripe Humana/virología , Masculino , Persona de Mediana Edad , Neumonía Viral/sangre , Neumonía Viral/diagnóstico por imagen , Neumonía Viral/mortalidad , Neumonía Viral/virología , Estudios Retrospectivos , Factores SexualesRESUMEN
Resumo A partir de contribuições teóricas do campo da história das ciências, o presente texto debate aspectos das etapas das pandemias entendidas como fenômeno social e como tem ocorrido o processo de interiorização da covid-19 na Amazônia. A chegada da doença aos vastos territórios da floresta tem deixado mais evidente o processo de acesso diferenciado à saúde pública, com concentração de serviços e profissionais nas maiores cidades da região Norte. O crescimento dos índices do coronavírus na floresta evidencia, portanto, as desigualdades sociais históricas da região e os problemas no acesso à cidadania na sociedade brasileira.
Abstract This text uses theoretical contributions from the history of science to discuss aspects of the stages of pandemics understood as social phenomena and how covid-19 moved into the interior of the Amazon region. The arrival of this disease in the vast forest territory made differentiated access to public health more evident, with services and professionals concentrated in the larger cities in the north of Brazil. The rise in coronavirus rates within the forest consequently highlights the history of social inequalities in the region and problems accessing citizenship in Brazilian society.
Asunto(s)
Humanos , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Bosques , Pandemias/historia , Pandemias/prevención & control , COVID-19/epidemiología , Accesibilidad a los Servicios de Salud , Pobreza , Factores Socioeconómicos , Brasil/epidemiología , Indígenas Sudamericanos , Salud Pública/historia , Ciudades , Gripe Humana/etiología , Gripe Humana/epidemiología , COVID-19/prevención & control , COVID-19/transmisiónRESUMEN
BACKGROUND: Recurrent acute otitis media in the first years of life can be explained by immune dysfunction. Consequently, it would be expected that otitis-prone (OP) children would be more susceptible to other infectious diseases, especially respiratory infections, since a component of the immune problem involves nasopharyngeal innate immunity. DESIGN: Cohort study with prospective identification of all physician-diagnosed, medically attended respiratory illness visits in children 6 months to 5 years of age to determine the incidence of pneumonia, acute sinusitis, influenza and other bacterial and viral infections among OP compared with non-OP (NOP) children. Tympanocentesis to microbiologically confirm acute otitis media disease. RESULTS: Two hundred eighty-five children were studied. Thirty-nine met a standard definition of stringently defined OP (sOP) determined by tympanocentesis and 246 were NOP. sOP children had increased frequency of presumptive respiratory infections, pneumonia (6-fold higher, P < 0.001), sinusitis (2.1-fold higher, P = 0.026) and influenza (2.9-fold higher, P = 0.002), compared with NOP children. Demographic and risk factor covariate-adjusted fold difference between sOP and NOP children for all respiratory infection illness visits was 2.4-fold (P < 0.00001) at 6-18 months of age, 2.2-fold (P < 0.00001) at 18-30 months of age and at age and 2.4-fold (P = 0.035) higher at 30 to 42 months. For both sOP and NOP children, more frequent medically attended respiratory infection illness visits from 6-18 months of age predicted more frequent visits experienced from 18-60 months of age. CONCLUSIONS: Clinicians should be aware of a significant increased likelihood of bacterial and viral respiratory infection proneness among OP children.
Asunto(s)
Gripe Humana/etiología , Otitis Media/complicaciones , Neumonía/etiología , Infecciones del Sistema Respiratorio/etiología , Sinusitis/etiología , Preescolar , Susceptibilidad a Enfermedades/etiología , Susceptibilidad a Enfermedades/microbiología , Susceptibilidad a Enfermedades/virología , Femenino , Humanos , Inmunidad Innata , Incidencia , Lactante , Masculino , Otitis Media/inmunología , Otitis Media/microbiología , Otitis Media/virología , Estudios Prospectivos , Recurrencia , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/virología , Factores de RiesgoRESUMEN
This text uses theoretical contributions from the history of science to discuss aspects of the stages of pandemics understood as social phenomena and how covid-19 moved into the interior of the Amazon region. The arrival of this disease in the vast forest territory made differentiated access to public health more evident, with services and professionals concentrated in the larger cities in the north of Brazil. The rise in coronavirus rates within the forest consequently highlights the history of social inequalities in the region and problems accessing citizenship in Brazilian society.
A partir de contribuições teóricas do campo da história das ciências, o presente texto debate aspectos das etapas das pandemias entendidas como fenômeno social e como tem ocorrido o processo de interiorização da covid-19 na Amazônia. A chegada da doença aos vastos territórios da floresta tem deixado mais evidente o processo de acesso diferenciado à saúde pública, com concentração de serviços e profissionais nas maiores cidades da região Norte. O crescimento dos índices do coronavírus na floresta evidencia, portanto, as desigualdades sociais históricas da região e os problemas no acesso à cidadania na sociedade brasileira.
Asunto(s)
COVID-19/epidemiología , Bosques , Accesibilidad a los Servicios de Salud , Pandemias , Brasil/epidemiología , COVID-19/prevención & control , COVID-19/transmisión , Ciudades , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Indígenas Sudamericanos , Gripe Humana/epidemiología , Gripe Humana/etiología , Pandemias/historia , Pandemias/prevención & control , Pobreza , Salud Pública/historia , Factores SocioeconómicosRESUMEN
BACKGROUND: Since the outbreak of coronavirus disease 2019 in December 2019, more than 8 million cases have occurred worldwide as of June 16, 2020. However, it is important to distinguish COVID-19 from other respiratory infectious diseases, such as influenza. Here, we comparatively described the clinical characteristics of children with COVID-19 and paediatric patients with influenza. METHODS: In this retrospective, single-centre study, we reviewed the electronic medical records of 585 paediatric patients with COVID-19 or influenza in Wuhan Children's Hospital, China. Clinical and epidemiological characteristics, laboratory findings, and clinical outcomes were comparatively analysed. RESULTS: The median ages were 6.96 years (IQR, 2-10.81) for children with confirmed COVID-19, 2.67 years (IQR, 1.03-15.25) for those with influenza A and 3.67 years (IQR, 1.62-5.54) for those with influenza B. Fever was a symptom in 84 (34.7%) COVID-19 cases, 132 (70.21%) influenza A cases and 111 (74.50%) influenza B cases. The median length of stay (LOS) was 11 (8-15) days for paediatric COVID-19 patients, 4 (3-6) days for influenza A patients and 5 (3-6) days for influenza B patients. Twenty-six (13.98%) influenza A patients and 18 (12.59%) influenza B patients presented with decreased white blood cell counts, while 13 (5.33%) COVID-19 patients presented with decreased white blood cell counts. Eight (3.28%) COVID-19 patients, 23 (12.71%) influenza A patients and 21 (14.79%) influenza B patients experienced lymphocytopenia. Acute cardiac injury occurred in 18 (7.29%) COVID-19 patients, while 37 (19.68%) influenza A and 27 (18.12%) influenza B patients had acute cardiac injury. CONCLUSION: In this study, the illnesses of children with COVID-19 were demonstrated to be less severe than those of paediatric patients with influenza, and COVID-19 patients had milder illness and fewer complications.
Asunto(s)
Tratamiento Farmacológico de COVID-19 , COVID-19/etiología , Gripe Humana/tratamiento farmacológico , Gripe Humana/etiología , Adolescente , COVID-19/epidemiología , Niño , Niño Hospitalizado , Preescolar , China/epidemiología , Comorbilidad , Femenino , Fiebre/epidemiología , Hospitales Pediátricos , Humanos , Lactante , Gripe Humana/epidemiología , Tiempo de Internación , Linfopenia/epidemiología , Linfopenia/virología , Masculino , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Síndrome de Dificultad Respiratoria/epidemiología , Síndrome de Dificultad Respiratoria/etiología , Síndrome de Dificultad Respiratoria/virología , Estudios RetrospectivosRESUMEN
BACKGROUND: It had been documented in many studies that pediatric coronavirus disease 2019 (COVID-19) is characterized by low infectivity rates, low mortalities, and benign disease course. On the other hand, influenza type A viruses are recognized to cause severe and fatal infections in children populations worldwide. This study is aimed to compare the clinical and laboratory characteristics of COVID-19 and H1N1 influenza infections. METHODS: A retrospective study comprising 107 children hospitalized at Abha Maternity and Children Hospital, Southern region of Saudi Arabia, with laboratory-confirmed COVID-19 and H1N1 influenza infections was carried out. A complete follow-up for all patients from the hospital admission until discharge or death was made. The clinical data and laboratory parameters for these patients were collected from the medical records of the hospital. RESULTS: Out of the total enrolled patients, 73 (68.2%) were diagnosed with COVID-19, and 34 (31.8%) were diagnosed with H1N1 influenza. The median age is 12 months for COVID-19 patients and 36 months for influenza patients. A relatively higher number of patients with influenza had a fever and respiratory symptoms than COVID-19 patients. In contrast, gastrointestinal symptoms were observed in a higher number of COVID-19 patients than in influenza patients. A statistically significant increase in white cell counts is noted in COVID-19 but not in influenza patients (P < 0.05). There are no obvious variations in the mean period of duration of hospitalization between COVID-19 and influenza patients. However, the total intensive care unit length of stay was longer for influenza compared to COVID-19 patients. CONCLUSIONS: A considerable number of children infected with COVID-19 and H1N1 influenza were noted and reported in this study. There were no significant variations in the severity of the symptomatology and laboratory findings between the two groups of patients. Significant differences between these patients in some hospitalization factors and diagnosis upon admission also were not observed. However, more severe clinical manifestations and serious consequences were observed among pediatric patients hospitalized with influenza infections than among those with COVID-19.
Asunto(s)
COVID-19/epidemiología , COVID-19/terapia , Niño Hospitalizado , Gripe Humana/etiología , Gripe Humana/terapia , Femenino , Humanos , Lactante , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/virología , Tiempo de Internación/estadística & datos numéricos , Masculino , Pronóstico , Estudios Retrospectivos , SARS-CoV-2 , Arabia Saudita/epidemiología , Índice de Severidad de la EnfermedadRESUMEN
OBJECTIVE: The present study seeks to analyse sociodemographic determinants related to severe acute respiratory infections (SARI) and calculate the priorization index in the cantons of Ecuador to identify areas probably most vulnerable to COVID-19 transmission. DESIGN: This descriptive ecological observational study. SETTING: 224 cantons (geographical area) of Ecuador with secondary data sources of hospital information. PARTICIPANTS: The unit of measurement was 224 cantons of Ecuador, in which analysed morbidity and lethality rates for SARI using hospital release data (2016-2018). MAIN MEASUREMENTS: Eight sociodemographic indicators were structuralized, and correlation tests applied for a multiple regression model. The priorization index was created with criteria of efficiency, efficacy, effect size (IRR) and equity. Using the sum of the index for each indicator, the priorization score was calculated and localized in a territorial map. RESULTS: Morbidity associated factors where: school attendance years, urbanization and population density; for mortality resulted: school attendance and ethnics (indigenous) IRR: 1.09 (IC95%:1.06-1.15) and IRR: 1.024 (IC95%:102-1.03) respectively. With lethality where related cantons, with population older than 60 years, IRR: 1.049 (IC95%: 1.03-1.07); 87 cantons had high priority mostly localized in the mountain region and the Morona Santiago Province. CONCLUSIONS: Morbidity and mortality of SARI in Ecuador are associated to social and demographic factors. Priorization exercises considering these factors permit the identification of vulnerable territories facing respiratory disease propagation. The social determinants characteristic for each territory should be added to known individual factors to analyse the risk and vulnerability for COVID in the population.
Asunto(s)
COVID-19/etiología , COVID-19/prevención & control , Determinantes Sociales de la Salud , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , COVID-19/epidemiología , COVID-19/transmisión , Niño , Preescolar , Ecuador/epidemiología , Ambiente , Femenino , Mapeo Geográfico , Humanos , Lactante , Recién Nacido , Gripe Humana/epidemiología , Gripe Humana/etiología , Gripe Humana/prevención & control , Gripe Humana/transmisión , Masculino , Persona de Mediana Edad , Pandemias , Medición de Riesgo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores Socioeconómicos , Poblaciones Vulnerables , Adulto JovenRESUMEN
BACKGROUND: The hospital-acquired influenza (HAI) were usually contributed to severe outcomes among the inpatients. Here, we performed a meta-analysis to summarize and quantify the epidemiological and clinical characteristics of HAI. METHODS: We performed a literature search thorough PubMed, Web of Science, Cochrane Library, Embase, Scopus and China National Knowledge Infrastructure (CNKI), and Wanfang databases for observational studies. Random/fix-effects models were used to obtain pooled proportion, odds ratio (OR), and weighted mean difference (WMD). RESULTS: A total of 14 studies involving 1483 HAI and 71849 non-hospital-acquired influenza infections (NHAI) cases were included.The proportion of the HAI among the influenza cases was 11.38% (95% confidence interval [CI]: 5.19%-19.55%) and it was increased after 2012 (6.15% vs 12.72%). The HAI cases were significantly older (WMDâ=â9.51, 95% CI: 0.04-18.98) and the patients with chronic medical diseases were at increased risk of HAI (ORâ=â1.85, 95% CI: 1.57-2.19). Among them, metabolic disorders (ORâ=â8.10, 95% CI: 2.46-26.64) ranked the highest danger, followed by malignancy (ORâ=â3.18, 95% CI: 2.12-4.76), any chronic diseases (ORâ=â2.81, 95% CI: 1.08-9.31), immunosuppression (ORâ=â2.13, 95% CI: 1.25-3.64), renal diseases (ORâ=â1.72, 95% CI:1.40-2.10), heart diseases (ORâ=â1.52, 95% CI: 1.03-1.44), and diabetes (ORâ=â1.22, 95% CI: 1.03-1.44). The HAI cases were more likely to experience longer hospital stay (WMDâ=â10.23, 95% CI: 4.60-15.85) and longer intensive care unit (ICU) stay (WMDâ=â2.99, 95% CI: 1.50-4.48). In the outcomes within 30 days, those population was still more likely to receive hospitalization (ORâ=â6.55, 95% CI: 5.19-8.27), death in hospital (ORâ=â1.99, 95% CI: 1.65-2.40) but less likely to discharged (ORâ=â0.20, 95% CI: 0.16-0.24). CONCLUSION: The proportion of the HAI among the influenza cases was relatively high. Reinforcement of the surveillance systems and vaccination of the high-risk patients and their contacts are necessary for the HAI control.
Asunto(s)
Infección Hospitalaria/epidemiología , Hospitalización/estadística & datos numéricos , Virus de la Influenza A , Gripe Humana/epidemiología , Vigilancia de la Población , Estudios de Casos y Controles , Infección Hospitalaria/virología , Estudios Transversales , Femenino , Humanos , Incidencia , Gripe Humana/etiología , Masculino , Oportunidad RelativaRESUMEN
OBJECTIVE: International guidelines recommend pneumococcal pneumonia and influenza vaccination for all patients with solid organ malignancies prior to initiating chemotherapy. Baseline vaccination rates (March 2019) for pneumococcal pneumonia and influenza at our tertiary cancer centre were 8% and 40%, respectively. The aim of this study was to increase the number of gynecologic chemotherapy patients receiving pneumococcal and influenza vaccinations to 80% by March 2020. METHODS: We performed an interrupted time series study using structured quality improvement methodology. Three interventions were introduced to address vaccination barriers: an in-house vaccination program, a staff education campaign, and a patient care bundle (pre-printed prescription, information brochure, vaccine record booklet). Process and outcome data were collected by patient survey and pharmacy audit and analyzed on statistical process control charts. RESULTS: We identified 195 eligible patients. Pneumococcal and influenza vaccination rates rose significantly from 5% to a monthly mean of 61% and from 36% to a monthly mean of 67%, respectively. The 80% target was reached for both vaccines during one or more months of study. The in-house vaccination and staff education programs were major contributors to the improvement, whereas the information brochure and record booklet were minor contributors. CONCLUSIONS: Three interventions to promote pneumococcal and influenza vaccination among chemotherapy patients resulted in significantly improved vaccination rates. Lessons learned about promoting vaccine uptake may be generalizable to different populations and vaccine types. In response to the global COVID-19 pandemic, initiatives to expand the program to all chemotherapy patients at our centre are underway.
Asunto(s)
Neoplasias de los Genitales Femeninos/complicaciones , Programas de Inmunización/organización & administración , Vacunas contra la Influenza , Gripe Humana/prevención & control , Vacunas Neumococicas , Neumonía Neumocócica/prevención & control , Mejoramiento de la Calidad/organización & administración , Instituciones Oncológicas/organización & administración , Femenino , Neoplasias de los Genitales Femeninos/tratamiento farmacológico , Encuestas de Atención de la Salud , Accesibilidad a los Servicios de Salud/organización & administración , Humanos , Gripe Humana/etiología , Ontario , Aceptación de la Atención de Salud/estadística & datos numéricos , Neumonía Neumocócica/etiología , Pautas de la Práctica en Medicina/normas , Pautas de la Práctica en Medicina/estadística & datos numéricos , Relaciones Profesional-Paciente , Centros de Atención Terciaria/organización & administraciónRESUMEN
Maoto, a traditional kampo medicine, has been clinically prescribed for influenza infection and is reported to relieve symptoms and tissue damage. In this study, we evaluated the effects of maoto as an herbal multi-compound medicine on host responses in a mouse model of influenza infection. On the fifth day of oral administration to mice intranasally infected with influenza virus [A/PR/8/34 (H1N1)], maoto significantly improved survival rate, decreased viral titer, and ameliorated the infection-induced phenotype as compared with control mice. Analysis of the lung and plasma transcriptome and lipid mediator metabolite profile showed that maoto altered the profile of lipid mediators derived from ω-6 and ω-3 fatty acids to restore a normal state, and significantly up-regulated the expression of macrophage- and T-cell-related genes. Collectively, these results suggest that maoto regulates the host's inflammatory response by altering the lipid mediator profile and thereby ameliorating the symptoms of influenza.
Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Mediadores de Inflamación/metabolismo , Virus de la Influenza A , Gripe Humana/tratamiento farmacológico , Gripe Humana/etiología , Gripe Humana/metabolismo , Preparaciones de Plantas/administración & dosificación , Transcriptoma/efectos de los fármacos , Animales , Antivirales , Modelos Animales de Enfermedad , Ephedra sinica , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Macrófagos/inmunología , Macrófagos/metabolismo , Macrófagos/patología , Ratones , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Infecciones por Orthomyxoviridae/etiología , Evaluación de Síntomas , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T/metabolismo , Carga Viral/efectos de los fármacosRESUMEN
BACKGROUND: Pregnant women are particularly vulnerable to severe infection from influenza resulting in poor neonatal outcomes. The majority of evidence relates to pandemic 2009 A/H1N1 influenza. The objective of this study was to describe the characteristics and outcomes of pregnant women hospitalised with seasonal influenza. METHODS: This national, prospective, observational cohort study used the UK Obstetric Surveillance System (UKOSS) to identify all pregnant women admitted to hospital between 01/11/2016 and 31/10/2018 with laboratory confirmed influenza at any gestation and up to two days after giving birth. These were compared to women admitted to give birth that did not have influenza. Baseline characteristics, immunization status, maternal and perinatal outcomes were compared. RESULTS: There were 405 women admitted to hospital with laboratory confirmed influenza in pregnancy: 2.7 per 10,000 maternities. Compared to 694 comparison women, women with influenza were less likely to be professionally employed (aOR 0.59, 95%CI 0.39-0.89) or immunised in the relevant season (aOR 0·59, 0·39-0·89) and more likely to have asthma (aOR 2.42, 1.30-4.49) or have had a previous pregnancy complication (aOR 2·47, 1·33-4·61). They were more likely to be admitted to intensive care (aOR 21.3, 2.78-163.1) and to have a cesarean birth (aOR 1·42, 1·02-1.98). Their babies were more likely to be admitted to neonatal intensive care (aOR 1.86, 1·01-3·42). CONCLUSIONS: Immunization reduces the risk of hospitalisation with influenza in pregnancy which is associated with increased risk of morbidity for both the mother and baby. There is a continued need to increase awareness of safety and effectiveness of immunization in pregnancy and provision within antenatal care settings, especially for high-risk groups.
Asunto(s)
Gripe Humana/epidemiología , Complicaciones Infecciosas del Embarazo/epidemiología , Adulto , Estudios de Cohortes , Femenino , Humanos , Incidencia , Gripe Humana/etiología , Embarazo , Complicaciones Infecciosas del Embarazo/etiología , Atención Prenatal , Estudios Prospectivos , Factores de Riesgo , Reino Unido/epidemiología , Adulto JovenRESUMEN
BACKGROUND: Influenza is a major cause of morbidity and mortality in Africa. However, a lack of epidemiological data remains for this pathology, and the performances of the influenza-like illness (ILI) case definitions used for sentinel surveillance have never been evaluated in Senegal. This study aimed to i) assess the performance of three different ILI case definitions, adopted by the WHO, USA-CDC (CDC) and European-CDC (ECDC) and ii) identify clinical factors associated with a positive diagnosis for Influenza in order to develop an algorithm fitted for the Senegalese context. METHODS: All 657 patients with a febrile pathological episode (FPE) between January 2013 and December 2016 were followed in a cohort study in two rural villages in Senegal, accounting for 1653 FPE observations with nasopharyngeal sampling and influenza virus screening by rRT-PCR. For each FPE, general characteristics and clinical signs presented by patients were collected. Sensitivity, Specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for the three ILI case definitions were assessed using PCR result as the reference test. Associations between clinical signs and influenza infection were analyzed using logistic regression with generalized estimating equations. Sore throat, arthralgia or myalgia were missing for children under 5 years. RESULTS: WHO, CDC and ECDC case definitions had similar sensitivity (81.0%; 95%CI: 77.0-85.0) and NPV (91.0%; 95%CI: 89.0-93.1) while the WHO and CDC ILI case definitions had the highest specificity (52.0%; 95%CI: 49.1-54.5) and PPV (32.0%; 95%CI: 30.0-35.0). These performances varied by age groups. In children < 5 years, the significant predictors of influenza virus infection were cough and nasal discharge. In patients from 5 years, cough, nasal discharge, sore throat and asthenia grade 3 best predicted influenza infection. The addition of "nasal discharge" as a symptom to the WHO case definition decreased sensitivity but increased specificity, particularly in the pediatric population. CONCLUSION: In summary, all three definitions studies (WHO, ECDC & CDC) have similar performance, even by age group. The revised WHO ILI definition could be chosen for surveillance purposes for its simplicity. Symptomatic predictors of influenza virus infection vary according the age group.